What is MK-2866 ?
Enobosarm, also formerly known as ostarine and by the developmental code names GTx-024 and MK-2866, is a selective androgen receptor modulator (SARM) which is under development for the treatment of breast cancer. It was also under development for a variety of other indications, including treatment of cachexia, Duchenne muscular dystrophy, muscular atrophy, and stress incontinence, but development for all other uses has been discontinued.
| Application: | Binds to androgen receptors |
| CAS: | 841205-47-8 |
| Molecular Weight: | 389.334 g·mol |
| Chemical Formula: | C19H14F3N3O3 |
| Chemical Name: | Enobosarm |
| Synonyms: | GTx-024; MK-2866; Ostarine; S-22, |
| Storage: | Minimize open air exposure, store in a cool dry place. |
| Stability: | 2 years |
| Purity: | 99% |
| Solubility: | Soluble to ethanol at rate of 25mg/ml |
| Organoleptic Profile: | White fine powder. |
| Physical Form: | fine powder in vegan capsule |
| Specifications: | 12.5mg/capsule |
| Container: | 60 Ostarine MK-2866 capsules |
| Terms: | The products we offer are intended for laboratory research use only. |
China
